Procurement Summary
Country: USA
Summary: Hereditary Hemorrhagic Telangiectasia (Hht) Center
Deadline: 10 Jul 2026
Posting Date: 09 Jun 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 142894021
Document Ref. No.: HRSA-26-092
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
The Purpose Of The Hereditary Hemorrhagic Telangiectasia (Hht) Center Program Is To Reduce Illness And Death Related To Hht By Partnering With Clinical Center To Expand Access And Coordination Of Care; Creating Innovative Strategies That Support Clinicians With Identifying And Diagnosing Hht Cases; And Developing A De-Identified, Aggregate Patient Data Registry To Better Understand This Rare Disease And Its Treatment Outcomes.Eligibilityeligible Applicantsgovernmentstate Governmentsmiscellaneousunrestrictedadditional Information"Domestic" Means The 50 States, The District Of Columbia, The Commonwealth Of Puerto Rico, The Northern Mariana Islands, American Samoa, Guam, The U.S. Virgin Islands, The Federated States Of Micronesia, The Republic Of The Marshall Islands, And The Republic Of Palau.Grantor Contact Informationdescriptionnordia Williams [email protected]@Hrsa.Govdocumentsfile Namedescriptionlast Updatedhrsa-26-092 Final.Pdfjun 8, 2026 04:20 Pm Utclink To Additional Information--Closing: July 10, 2026
Award max: $2, 900, 000
Posted Date: 2026-06-08 00:00:00
Funding instrument type: Cooperative agreement
Documents
Tender Notice